Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Global X NASDAQ 100 Covered Call ETF (QYLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Global X NASDAQ 100 Covered Call ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Global X NASDAQ 100 Covered Call ETF trades at $18.63 (market cap $8.54B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 3.6× Global X NASDAQ 100 Covered Call ETF's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Global X NASDAQ 100 Covered Call ETF pays none. Which is the better fit depends on your goals.
| GEHC | QYLD | |
|---|---|---|
Market Cap | $30.93B | $8.54B |
Volume | 5,033,451 | 2,727,578 |
Sector | Health | Income / Options Overlay |
52-Week High | $88.16 | $18.69 |
52-Week Low | $59.48 | $16.70 |
Enterprise Value | $39.39B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 51 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
QYLD trades at $18.69, showing minimal daily movement with a 0.05% gain. The ETF maintains its covered call strategy on the Nasdaq 100, generating consistent monthly dividends of $0.18 per share. Technical indicators show mixed signals with moving averages bullish but oscillators bearish, while RSI levels above 75 suggest overbought conditions. Recent news highlights concerns about principal erosion despite the attractive yield.
The outlook remains cautious as QYLD's high yield comes with capped upside potential during market rallies. While providing reliable monthly income, the strategy sacrifices long-term capital appreciation. Key risks include declining option premiums and tax treatment uncertainties that could impact total returns for income-focused investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Global X NASDAQ 100 Covered Call ETF
QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →
